Skip to main content
. 2014 Dec 10;12:340. doi: 10.1186/s12967-014-0340-9

Figure 5.

Figure 5

Pharmacokinetic profile of LCI699 following once-daily oral administration in humans. Plasma concentration–time profile for LCI699 (mg dose of phosphate salt) on Day 14 following once-daily oral administration in healthy human volunteers for 14 days. Values are mean ± SD. Number of evaluable subjects for LCI699 0.5, 1 and 3 mg were n = 12, 12 and 9 respectively.